Search Within

Michel W J Sadelain

Formats
  1. Meeting Abstract (289)
  2. Journal Article (279)
  3. Review (5)
  4. Editorial (4)
  5. Conference Paper (3)
  6. Research Letter (3)
  7. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (585)
  2. Department of Medicine (585)
  3. GSK Faculty (585)
  4. Hematologic Malignancies Research (585)
  5. Hematologic Malignancies, Division of (585)
  6. Molecular Pharmacology and Chemistry Program Faculty (585)

More Groups

People
  1. Isabelle Riviere (200)
  2. Renier Brentjens (116)
  3. Xiuyan Wang (91)
  4. Jae Park (83)
  5. Jorge Mansilla-Soto (43)
  6. Kevin Curran (36)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (21)
  4. 2022 (18)
  5. 2021 (23)
  6. 2020 (16)

More Years

Publications
  1. Blood (133)
  2. Molecular Therapy (56)
  3. Cancer Research (24)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Blood Cells, Molecules, and Diseases (12)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. Nature Publishing Group (126)
  3. Elsevier Inc. (49)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (19)
  6. Cell Press (16)

More Publishers

Results (585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting CARs to the TRAC locus enhances T-cell potency
    Meeting Abstract

    Sadelain, M.; Eyquem, J.
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • CD19 CAR T cells
    Journal Article

    Sadelain, M.
    Cell (2017)

    Fulltext@MSK | Save
  • Integrating proteomics and transcriptomics for systematic combinatorial chimeric antigen receptor therapy of AML
    Journal Article

    Perna, F.; Berman, S. H.; Soni, R. K.; Mansilla-Soto, J.; Eyquem, J.; Hamieh, M.; Hendrickson, R. C.; Brennan, C. W.; Sadelain, M.
    Cancer Cell (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptors: A cell and gene therapy perspective
    Journal Article

    Rivière, I.; Sadelain, M.
    Molecular Therapy (2017)

    Fulltext@MSK | Save
  • Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: Expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Journal Article

    Eguchi, T.; Kadota, K.; Mayor, M.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Santomasso, B.; Sadelain, M.; Brentjens, R.
    Haematologica (2017)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Therapeutic T cell engineering
    Journal Article

    Sadelain, M.; Rivière, I.; Riddell, S.
    Nature (2017)

    Fulltext@MSK | Save
  • Disease burden and transplant on long-term survival after CD19 CAR T cells in adults with relapsed acute lymphoblastic leukemia
    Meeting Abstract

    Park, J.; Rivere, I.; Wang, X. Y.; Senechal, B.; Curran, K.; Sauter, C.; Wang, Y. Z.; Li, D.; Brentjens, R.; Sadelain, M.
    Molecular Therapy (2017)

    Fulltext@MSK | Save